Momentum Stocks

Bull of the Day: Incyte (INCY) – Bull of the Day

Incyte Corporation (INCY) is a $12 billion pharmaceutical company that is expected to finally turn a profit next year on the success of its drug Jakafi, the only FDA-approved treatment for myelofibrosis (MF). Incyte was formerly called Incyte Genomics in the 1990s when it was a pioneer in that groundbreaking research and a key provider of database information on the human genome to the world’s top pharmaceutical companies. Jakafi (ruxolitinib) has been used to treat more than 9,800 patients with MF worldwide and will represent over $350 million of the company’s $500 million in revenues for 2014 […]

Max Keiser

Keiser Report: Big Kaputski of 2015 (E700)

[youtube YOAbUb7hMgE] Max Keiser and Stacy Herbert celebrate the first day of 2015 with some regular guests who attempt to predict the big themes of the New Year. First, they talk to Dominic Frisby of Moneyweek.com about where it all might kick off this year – perhaps Japan? […]

Downgrades

CNA FINL CORP (CNA) Downgraded by Zacks to UNDERPERFORM

Zacks Investment Research downgraded shares of CNA FINL CORP (CNA) from NEUTRAL to UNDERPERFORM on January 01, 2015, with a target price of $36.80. CNA Financial Corporation is an insurance holding company whose primary subsidiaries consist of property/casualty and life insurance companies. CNA's property/casualty insurance operations are conducted by Continental Casualty Company and The Continental Insurance Company […]

Mergers & Acquisitions

Lilly Finalizes Novartis Animal Health Acquisition

Lilly Finalizes Novartis Animal Health Acquisition PR Newswire INDIANAPOLIS, Jan. 1, 2015 INDIANAPOLIS , Jan. 1, 2015 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that it has completed the acquisition of Novartis Animal Health, which will further position Lilly’s Elanco as a global leader in the animal health industry […]